FDA investigating reports of hospitalizations after fake Ozempic

FDA investigating reports of hospitalizations after fake Ozempic

At least three Americans were reportedly hospitalized after using suspected counterfeit semaglutide medications, including Novo Nordisk’s diabetes drug Ozempic, according to records released by the Food and Drug Administration. Ozempic and Wegovy, another semaglutide drug from Novo Nordisk, have been in shortage for months amid booming sales for their use… Continue Reading FDA investigating reports of hospitalizations after fake Ozempic